BDBM278540 (2E)-3-(3-Methyl-1-{[5-(3-methyloxetan-3-yl)-3-(2,4,6-trichlorophenyl)-1,2-oxazol-4-yl]carbonyl}-1H-indol-4-yl)prop-2-enoic acid ::US10040791, Example 2

SMILES: Cc1cn(C(=O)c2c(noc2C2(C)COC2)-c2c(Cl)cc(Cl)cc2Cl)c2cccc(\C=C\C(O)=O)c12

InChI Key: InChIKey=HYWBLOXYWSBDNM-VOTSOKGWSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 278540   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
IDH1 R132C (Homo sapiens (Human))	BDBM278540 ( (2E)-3-(3-Methyl-1-{[5-(3-methyloxetan-3-yl)-3-(2...) Show SMILES Cc1cn(C(=O)c2c(noc2C2(C)COC2)-c2c(Cl)cc(Cl)cc2Cl)c2cccc(\C=C\C(O)=O)c12 |(3.32,.91,;1.98,.14,;.52,.62,;-.39,-.63,;-1.93,-.63,;-2.57,-1.74,;-2.7,.7,;-4.24,.7,;-4.71,2.17,;-3.47,3.07,;-2.22,2.17,;-.89,2.94,;.45,2.17,;.2,4.03,;-.89,5.12,;-1.98,4.03,;-5.28,-1.12,;-6.82,-1.12,;-7.59,.22,;-7.59,-2.45,;-6.82,-3.78,;-7.59,-5.12,;-5.28,-3.78,;-4.51,-2.45,;-2.97,-2.45,;.52,-1.87,;.2,-3.38,;1.34,-4.41,;2.81,-3.94,;3.13,-2.43,;4.61,-2.03,;5.01,-.54,;6.5,-.14,;7.59,-1.23,;6.9,1.34,;1.98,-1.4,)| Show InChI InChI=1S/C26H19Cl3N2O5/c1-13-10-31(18-5-3-4-14(20(13)18)6-7-19(32)33)25(34)22-23(21-16(28)8-15(27)9-17(21)29)30-36-24(22)26(2)11-35-12-26/h3-10H,11-12H2,1-2H3,(H,32,33)/b7-6+	PDB GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	47	n/a	n/a	n/a	n/a	7.5	25
Daiichi Sankyo Company, Limited; National Cancer Center US Patent					Assay Description The IDH1R132H protein and the IDH1R132C protein were prepared as follows: the IDH1R132H or IDH1R132C gene was integrated into a pET24b(+) vector (Nov...				US Patent US10040791 (2018) BindingDB Entry DOI: 10.7270/Q2JS9SF8
					More data for this Ligand-Target Pair
IDH1 R132H (Homo sapiens (Human))	BDBM278540 ( (2E)-3-(3-Methyl-1-{[5-(3-methyloxetan-3-yl)-3-(2...) Show SMILES Cc1cn(C(=O)c2c(noc2C2(C)COC2)-c2c(Cl)cc(Cl)cc2Cl)c2cccc(\C=C\C(O)=O)c12 |(3.32,.91,;1.98,.14,;.52,.62,;-.39,-.63,;-1.93,-.63,;-2.57,-1.74,;-2.7,.7,;-4.24,.7,;-4.71,2.17,;-3.47,3.07,;-2.22,2.17,;-.89,2.94,;.45,2.17,;.2,4.03,;-.89,5.12,;-1.98,4.03,;-5.28,-1.12,;-6.82,-1.12,;-7.59,.22,;-7.59,-2.45,;-6.82,-3.78,;-7.59,-5.12,;-5.28,-3.78,;-4.51,-2.45,;-2.97,-2.45,;.52,-1.87,;.2,-3.38,;1.34,-4.41,;2.81,-3.94,;3.13,-2.43,;4.61,-2.03,;5.01,-.54,;6.5,-.14,;7.59,-1.23,;6.9,1.34,;1.98,-1.4,)| Show InChI InChI=1S/C26H19Cl3N2O5/c1-13-10-31(18-5-3-4-14(20(13)18)6-7-19(32)33)25(34)22-23(21-16(28)8-15(27)9-17(21)29)30-36-24(22)26(2)11-35-12-26/h3-10H,11-12H2,1-2H3,(H,32,33)/b7-6+	PDB GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	25
Daiichi Sankyo Company, Limited; National Cancer Center US Patent					Assay Description The IDH1R132H protein and the IDH1R132C protein were prepared as follows: the IDH1R132H or IDH1R132C gene was integrated into a pET24b(+) vector (Nov...				US Patent US10040791 (2018) BindingDB Entry DOI: 10.7270/Q2JS9SF8
					More data for this Ligand-Target Pair